📗 Cite This Artifact
TFEB Protein (Transcription Factor EB)
TFEB Protein (Transcription Factor EB)
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TFEB Protein (Transcription Factor EB)</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Agent/Strategy</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Trehalose</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Amiodarone</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-[TFEB](/proteins/tfeb)</td>
</tr>
<tr>
<td class="label">Natural compounds</td>
<td>Resveratrol</td>
</tr>
<tr>
<td class="label">Small molecule inhibitors</td>
<td>Rapamycin</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Trehalose</td>
<td>AMPK activation, autophagy induction</td>
</tr>
<tr>
<td class="label">Lithium</td>
<td>IMPase inhibition, mTOR-independent</td>
</tr>
<tr>
<td class="label">Genistein</td>
<td>Tyrosine kinase inhibition</td>
</tr>
<tr>
<td class="label">Verapamil</td>
<td>Calcium channel blockade</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">AMYOTROPHIC LATERAL SCLEROSIS</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">ATA
TFEB Protein (Transcription Factor EB)
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TFEB Protein (Transcription Factor EB)</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Agent/Strategy</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Trehalose</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Amiodarone</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-[TFEB](/proteins/tfeb)</td>
</tr>
<tr>
<td class="label">Natural compounds</td>
<td>Resveratrol</td>
</tr>
<tr>
<td class="label">Small molecule inhibitors</td>
<td>Rapamycin</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Trehalose</td>
<td>AMPK activation, autophagy induction</td>
</tr>
<tr>
<td class="label">Lithium</td>
<td>IMPase inhibition, mTOR-independent</td>
</tr>
<tr>
<td class="label">Genistein</td>
<td>Tyrosine kinase inhibition</td>
</tr>
<tr>
<td class="label">Verapamil</td>
<td>Calcium channel blockade</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">AMYOTROPHIC LATERAL SCLEROSIS</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">ATAXIA</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-e5a1c16b" style="color:#ce93d8" title="Score: 0.50">TFEB-PGC1α Mitochondrial-Lysosomal Decou...</a><br><a href="/hypothesis/h-e3e8407c" style="color:#ce93d8" title="Score: 0.50">The Mitochondrial-Lysosomal Metabolic Co...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1708 edges</a></td>
</tr>
</table>
[Tfeb](/entities/tfeb) Protein (Transcription Factor Eb) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Pathway / Mechanism Diagram
Overview
[TFEB](/proteins/tfeb) (Transcription Factor EB) is a basic helix-loop-helix leucine zipper (bHLH-Zip) transcription factor that serves as the master regulator of lysosomal biogenesis and [autophagy](/entities/autophagy). It controls the expression of genes involved in the lysosomal-autophagic pathway, mitochondrial quality control, and lipid metabolism. [TFEB](/proteins/tfeb) is a critical therapeutic target in neurodegenerative diseases where autophagy-lysosomal dysfunction plays a central role.
Structure
[TFEB](/proteins/tfeb) is a 53 kDa protein consisting of:
- N-terminal bHLH domain (aa 1-100): DNA binding domain that recognizes CLEAR motifs (TGTCACGTGAC) in target gene promoters
- Zip domain (aa 130-200): Leucine zipper for dimerization with other transcription factors
- Regulatory domain: Contains serine residues (Ser142, Ser211) that are phosphorylated by [mTOR](/proteins/mtor-protein)C1, controlling nuclear localization
- C-terminal domain: Transactivation domain for recruiting co-activators
The crystal structure of [TFEB](/proteins/tfeb)'s DNA-binding domain has been solved (PDB: 5W5V), revealing a typical bHLH fold that homodimerizes to bind DNA.
Normal Function
[TFEB](/proteins/tfeb) is constitutively expressed in most cell types, with highest expression in tissues with high lysosomal activity including:
Lysosomal Biogenesis
[TFEB](/proteins/tfeb) activates the Coordinated Lysosomal Expression and Regulation (CLEAR) network, which includes:
- Lysosomal hydrolases (cathepsins, β-glucocerebrosidase)
- Lysosomal membrane proteins ([LAMP1](/proteins/lamp1), LAMP2, NPC1)
- Autophagy-related genes (LC3, ATG proteins)
- Transcription factor MITF, TFE3 ([TFEB](/proteins/tfeb) family members)
Autophagy Regulation
- Induces expression of autophagic genes
- Promotes nuclear translocation of TF during starvation
- Coordinates mitochondrial fission and mitophagy via PGC-1α activation
Lipid Metabolism
- Regulates genes involved in fatty acid oxidation
- Controls cholesterol efflux via ABCA1 expression
- Modulates lipid droplet formation and breakdown
Role in Disease
[Alzheimer's Disease](/diseases/alzheimers-disease)
- [TFEB](/proteins/tfeb) activity is reduced in AD brains, leading to impaired lysosomal function and Aβ accumulation
- Aβ oligomers inhibit [TFEB](/proteins/tfeb) nuclear translocation
- Restoring [TFEB](/proteins/tfeb) activity promotes clearance of Aβ and [tau](/proteins/tau) pathology
- [TFEB](/proteins/tfeb) activation enhances neurite outgrowth and synaptic plasticity
Parkinson's Disease
- [TFEB](/proteins/tfeb)-mediated autophagy is crucial for clearing α-synuclein aggregates
- Loss of [TFEB](/proteins/tfeb) function contributes to dopaminergic neuron vulnerability
- PINK1 and Parkin activate [TFEB](/proteins/tfeb) to promote mitophagy
- [TFEB](/proteins/tfeb) activators protect against MPTP-induced dopaminergic degeneration
[Huntington's Disease](/mechanisms/huntington-pathway)
- [TFEB](/proteins/tfeb) activation reduces mutant [huntingtin](/genes/htt) aggregation
- Enhances clearance of polyglutamine-expanded proteins
- Improves mitochondrial function and reduces oxidative stress
Amyotrophic Lateral Sclerosis
- [TFEB](/proteins/tfeb) promotes clearance of mutant SOD1 and [TDP-43](/mechanisms/tdp-43-proteinopathy) aggregates
- Protects motor [neurons](/entities/neurons) from proteotoxic stress
- Regulates lysosomal function in [microglia](/cell-types/microglia-neuroinflammation)
Therapeutic Targeting
Key Publications
Cross-links
- [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway) - [TFEB](/proteins/tfeb) is master regulator
- [/proteins/mtor|[mTOR](/proteins/mtor-protein)] - phosphorylates and inhibits [TFEB](/proteins/tfeb)
- [LAMP1](/proteins/lamp1) - lysosomal proteins regulated by [TFEB](/proteins/tfeb)
- [Cathepsin D](/proteins/cathepsin-d) - lysosomal protease regulated by [TFEB](/proteins/tfeb)
- [/diseases/alzheimers|[Alzheimer's Disease](/diseases/alzheimers-disease)] - [TFEB](/proteins/tfeb) dysfunction in AD
- [Parkinson's Disease](/diseases/parkinsons-disease-disease) - [TFEB](/proteins/tfeb) in α-syn clearance
- [/diseases/huntingtons|[Huntington's Disease](/mechanisms/huntington-pathway)] - [TFEB](/proteins/tfeb) clears mutant huntingtin
- [genes/tfeb|[TFEB](/proteins/tfeb) Gene]
External Links
- [UniProt: TFEB](https://www.uniprot.org/Q9XBK8)
- [PDB: TFEB Structure](https://www.ebi.ac.uk/pdbe/entry/pdb/5w5v)
- [TFEB](/proteins/tfeb) research consortium](https://autophagy.ulg.ac.be/)
Background
The study of Tfeb Protein (Transcription Factor Eb) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
- [Tau Pathology](/mechanisms/tau-pathology)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alpha-Synuclein](/mechanisms/alpha-synuclein)
Brain Atlas Resources
- [Allen Human Brain Atlas*: [TFEB PROTEIN (TRANSCRIPTION FACTOR EB) expression](https://human.brain-map.org/microarray/search/show?search_term=TFEB PROTEIN (TRANSCRIPTION FACTOR EB))](/datasets/allen-human-brain-atlas)
- [Allen Cell Type Atlas*: [TFEB PROTEIN (TRANSCRIPTION FACTOR EB) cell type expression](https://celltypes.brain-map.org/)](/cell-types/atlas)
- [BrainSpan*: [TFEB PROTEIN (TRANSCRIPTION FACTOR EB) developmental expression](https://brainspan.org/)](/projects/brainspan)
TFEB in Neurodegenerative Diseases
Alzheimer's Disease
TFEB dysfunction contributes to AD pathogenesis through multiple mechanisms[@xiao2022]:
- [Amyloid metabolism*: TFEB regulates genes involved in [amyloid precursor protein](/entities/app-protein) (APP) processing and A](/entities)β clearance
- [Tau](/proteins/tau) pathology: TFEB promotes lysosomal degradation of tau aggregates
- Neuronal survival: TFEB activation protects against [amyloid-beta](/proteins/amyloid-beta) toxicity
- Lipid metabolism: TFEB regulates cholesterol efflux and lipid droplet formation
In AD brains, TFEB nuclear localization is reduced, indicating impaired TFEB activity. Restoring TFEB function through pharmacological activation represents a therapeutic strategy.
Parkinson's Disease
TFEB is particularly relevant in PD due to its role in [alpha-synuclein](/proteins/alpha-synuclein) clearance[@decressac2020]:
- Alpha-synuclein clearance: TFEB enhances macroautophagy-mediated degradation of alpha-synuclein aggregates
- Mitochondrial quality control: TFEB activates mitophagy through PGC-1α regulation
- Dopaminergic neuron protection: TFEB overexpression protects dopaminergic neurons in models of PD
LRRK2 (leucine-rich repeat kinase 2) mutations, a major cause of familial PD, impair TFEB nuclear translocation, linking PD genetics to lysosomal dysfunction.
Amyotrophic Lateral Sclerosis
TFEB in ALS[@chen2021]:
- TDP-43 clearance: TFEB promotes degradation of TDP-43 aggregates
- Motor neuron survival: TFEB activation protects against oxidative stress
- [C9orf72](/entities/c9orf72) connection: TFEB dysfunction may contribute to C9orf72-mediated ALS
TFEB Activation Mechanisms
mTOR-Dependent Regulation
TFEB is phosphorylated by mTORC1 at Ser142 and Ser211[@napolitano2018]:
- Phosphorylated TFEB is retained in the cytoplasm
- [mTOR](/mechanisms/mtor-signaling-pathway) inhibition (e.g., by rapamycin) causes TFEB nuclear translocation
- mTOR-independent pathways also regulate TFEB (e.g., ERK2, GSK3β)
mTOR-Independent Activation
Several compounds activate TFEB independently of mTOR inhibition:
Therapeutic Approaches
Pharmacological TFEB Activators
Gene Therapy
AAV-mediated TFEB overexpression shows promise[@palmieri2021]:
- Restores lysosomal function in animal models
- Clears protein aggregates in AD/PD models
- Current focus on brain-targeting and safe expression levels
Combination Strategies
TFEB activation may be combined with:
- Anti-aggregation compounds
- Proteostasis modulators
- Neuroprotective agents
TFEB Target Genes
TFEB regulates hundreds of genes through binding to CLEAR (Coordinated Lysosomal Expression and Regulation) elements:
Lysosomal Genes
- LAMP1, LAMP2: Lysosomal membrane proteins
- CTSA, CTSB, CTSD: Cathepsins
- GAA: Acid alpha-glucosidase
Autophagy Genes
- ATG genes: ATG5, ATG7, ATG16L1
- LC3 (MAP1LC3B): Autophagosome marker
- SQSTM1/p62: Selective autophagy receptor
Transcription Factors
- TFE3: TFEB family member
- MITF: Melanocyte-specific TFEB family
- PGC-1α (PPARGC1A): Mitochondrial biogenesis
References
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [TFEB-PGC1α Mitochondrial-Lysosomal Decoupling](/hypothesis/h-e5a1c16b) — <span style="color:#ffd54f;font-weight:600">0.52</span> · Target: TFEB
- [The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction](/hypothesis/h-e3e8407c) — <span style="color:#ffd54f;font-weight:600">0.52</span> · Target: TFEB
Pathway Diagram
The following diagram shows the key molecular relationships involving TFEB Protein (Transcription Factor EB) discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-tfeb |
| kg_node_id | TFEB |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-26f240b07652 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-tfeb'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-tfeb?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[TFEB Protein (Transcription Factor EB)](http://scidex.ai/artifact/wiki-proteins-tfeb)
http://scidex.ai/artifact/wiki-proteins-tfeb